Results 1 to 10 of about 354,007 (274)

Protective effect of cysteinyl leukotriene receptor antagonist montelukast in bleomycin-induced pulmonary fibrosis. [PDF]

Turk Gogus Kalp Damar Cerrahisi Derg, 2018
Topaloğlu N, Olgun Yıldızeli Ş, Şener G, Laçin T, Şehirli Ö, Bozkurtlar E, Çelikel Ç, Ceyhan B.   +7 more
europepmc   +1 more source

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Pediatrics, 2001
B. Knorr, L. Franchi, H. Bisgaard, J. Vermeulen, P. Le Souëf, N. Santanello, T. Michele, Theodore F. Reiss, Ha H. Nguyen, Donna L. Bratton   +9 more
semanticscholar   +1 more source

Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma. [PDF]

Exp Ther Med, 2017
Yoshihara S, Kikuchi Y, Saitou M, Yanagawa S, Kanno N, Igarashi H, Fukuda H, Iimura A, Abe T, Yamada Y, Andou T, Arisaka O.   +11 more
europepmc   +1 more source

Leukotriene Receptor Antagonists: Clinical Effects [PDF]

Journal of the Royal Society of Medicine, 1997
openaire   +2 more sources

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

British medical journal, 1999
C. Löfdahl, T. Reiss, J. Leff, E. Israel, M. Noonan, A. Finn, B. Seidenberg, T. Capizzi, S. Kundu, Philippe Godard   +9 more
semanticscholar   +1 more source

Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injury

Brain Injury, 2009
Necat Biber, H. Toklu, S. Solakoğlu, Mıne Gultomruk, T. Hakan, Z. Berkman, F. Dulger   +6 more
semanticscholar   +1 more source

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.

Thorax, 1997
T. Reiss, James B. Hill, E. Harman, Ji Zhang, W. Tanaka, E. Bronsky, Debra Guerreiro, L. Hendeles   +7 more
semanticscholar   +1 more source

The leukotriene receptor antagonist montelukast and aortic stenosis. [PDF]

Br J Clin Pharmacol, 2013
Bäck M, Yin L, Nagy E, Ingelsson E.
europepmc   +1 more source

A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis. [PDF]

Allergy, 2017
Okubo K, Hashiguchi K, Takeda T, Baba K, Kitagoh H, Miho H, Tomomatsu H, Yamaguchi S, Odani M, Yamamotoya H.   +9 more
europepmc   +1 more source

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

European Respiratory Journal, 1998
M. Noonan, P. Chervinsky, M. Brandon, Ji Zhang, S. Kundu, J. McBurney, T. Reiss   +6 more
semanticscholar   +1 more source